> I don’t know how many people listen to the webcasting of Thomas
> Weisel
> Partners Healthcare Conference; no matter you did it or not, let’s go
> over some important details of this conference. I am sure that even
> those people who have no ideas of drug industry will admit that it is
> so unbelievable after making a comparison of LGND’s real value and
> current stock price:

> 1, LGND has 10 pharmaceutical deals, with over 21 development
> programs. The programs not only have a chance to generate substantial
> milestones, over $600 million in milestones, but also future
> royalties. For royalties incomes, please refer to AVINZA which was
> sold to King and brings ten of millions dollars royalty to LGND every
> year.

> 2, the 11 million dollars stock for stock merger agreement with NRGN
> will bring LGND about 7 million dollars hard cash plus access to
> NRGN’s pipeline. Please remember this: Just the Merck full sponsored
> pain drug VR1 will bring LGND 10 million dollars milestone payment
> once Merk start Phase 3 clinical trial. VR1 is now at Phase 2.

> NRGN also has programs for Parkinson's Disease and Insomnia.

> After listening to the webcasting, I told my friends: “this deal is
> as
> beautiful as the deal which Lakers got Pau Gasol from Grizzlies.”

> 3, I already introduced LGND’s pipeline in my last article, and there
> is a more detailed programs outline from this conference. If you are
> interested in it, you can find it in my blog at Motley Fool (my
> screen
> name is AndrewGreenBull).

> There is one thing I have to emphasize: LGND sold AVINZA and four
> other drugs to King and another Japanese company for 500+million
> dollars in 2006, and there was $2.5 dividend payout in 2007 after the
> deals were finished. Now I want to ask you readers a question, if
> LGND
> sold 21 drugs or the whole company( I believe quite a few drug makers
> are interested in it), will it cost only $2.5/Share?

> The answer is quite obvious: absolutely not! Simply think about this:
> after the merger agreement with NRGN finished by the end of this
> year,
> LGND will have total 50 million dollars cash in hand, and the current
> stock price is not even 1/5 of its real value.

> 4, there were two more big surprises from the conference:

> One is that collaboration with BMS in the area of B38 MAP kinase
> inhibitors. The collaboration started about 12 years ago. It has
> generated various leads. Right now, BMS is running three Phase II
> studies in rheumatoid arthritis, psoriasis, and arthrosclerosis. The
> larger of the three, the rheumatoid arthritis trial, completed
> accrual
> in July this year, and the data are expected next month.

> I can smell that the milestone payment is nearby.

> Another one is PROMACTA again; a lead drug partnership with GSK,
> phase
> 3 data is expected to be released at ASH in New Orleans in December.
> LGND has a potential for earning over $10 million in milestone
> payments from existing collaborations.

> P.S. don’t forget Wyeth’s and Pfizer’s 3 NDA submissions.

> When tons good news coming on the way, and the current stock price is
> below 50 days average and 200 days average, my intuition tell me that
> LGND is oversold.

> Current Price $2.37　　　　My 3 Month Target：$5　　　My One Year Target：$10

> References: Please go to my blog at Motley Fool and search my screen
> name AndrewGreenBull, and you will find them there.

> * Statement: The author of this article is not a licensed analyst and
> the purpose of this article is for information sharing and discussion
> only, not recommendation for any stock buying, selling and shorting
> activities. Please do your own research before making any trading
> decision.

> KASC Investments published STOCKshttp://kashstockprofits.web.officelive.com

> CDC needs to break its trading range to follow a good UPTREND..

> On Sep 15, 10:23 am, Shawn <linges1...@yahoo.com> wrote:

> > its gonna for a rally... maybe up to 3 dollars in blink of eyes....

> > On Sep 15, 2:32 am, A H <kosherricebur...@gmail.com> wrote:

> > > Stock will hit $3 much earlier than Q3 results, perhaps might go back
> > > to mid 3's to 4's when Q3 comes around, perhaps new business coming in
> > > for CDC Software means more revenue for CDC Corp...

> > > On Sep 10, 11:59 am, jackson <wit...@gmail.com> wrote:

> > > > I did make a lot of money from CDC, when it was moving up a lot..and
> > > > keep on moving..
> > > > Was moving too fast and too much so I got out..put my $$$ into MIPS..
> > > > So far MIPS is doing very good.. look at that yourself ..may be a good
> > > > stock for you ..look at its YTD chart ...

> > > > On Sep 10, 11:12 am, vinip <yifeid...@gmail.com> wrote:

> > > > > i'm only holding my shares because my mom bought them when i todl her
> > > > > not to and wouldnt let me sell them when they were at 7. but yes this
> > > > > company is complete sh1t, so disappointing, horrible management.

> > > > > On Sep 3, 3:08 pm, A H <kosherricebur...@gmail.com> wrote:

> > > > > > CDC will in time go up again to at least $3 when Q3 results rolls
> > > > > > around.

> > > > > > On Sep 3, 9:36 am, ocean <caiwen_y...@yahoo.com> wrote:

> > > > > > > hopefully, CDC is not going to follow the same pattern as the
> > > > > > > history.

> > > > > > > On Aug 28, 7:24 pm, harvey <xushanhua1...@gmail.com> wrote:

> > > > > > > > When CDC was at $6, CDC CEO Peter Yip announced CDC was undervalued.
> > > > > > > > Then CDC went to $3.
> > > > > > > > When CDC was at $3,  CDC CEO Peter Yip announced CDC was undervalued.
> > > > > > > > Then CDC went to $0.7.
> > > > > > > > When CDC was at $0.7, CDC CEO Peter Yip didn't announce CDC was
> > > > > > > > undervalued. Then CDC went to $2.6.
> > > > > > > > When CDC  is at $2.6, CDC CEO Peter Yip announced CDC is undervalued.
> > > > > > > > Then CDC goes to ??????????????????????.

> > > > > > > > We will see!!!- Hide quoted text -

> > - Show quoted text -

> its gonna for a rally... maybe up to 3 dollars in blink of eyes....

> On Sep 15, 2:32 am, A H <kosherricebur...@gmail.com> wrote:

> > Stock will hit $3 much earlier than Q3 results, perhaps might go back
> > to mid 3's to 4's when Q3 comes around, perhaps new business coming in
> > for CDC Software means more revenue for CDC Corp...

> > On Sep 10, 11:59 am, jackson <wit...@gmail.com> wrote:

> > > I did make a lot of money from CDC, when it was moving up a lot..and
> > > keep on moving..
> > > Was moving too fast and too much so I got out..put my $$$ into MIPS..
> > > So far MIPS is doing very good.. look at that yourself ..may be a good
> > > stock for you ..look at its YTD chart ...

> > > On Sep 10, 11:12 am, vinip <yifeid...@gmail.com> wrote:

> > > > i'm only holding my shares because my mom bought them when i todl her
> > > > not to and wouldnt let me sell them when they were at 7. but yes this
> > > > company is complete sh1t, so disappointing, horrible management.

> > > > On Sep 3, 3:08 pm, A H <kosherricebur...@gmail.com> wrote:

> > > > > CDC will in time go up again to at least $3 when Q3 results rolls
> > > > > around.

> > > > > On Sep 3, 9:36 am, ocean <caiwen_y...@yahoo.com> wrote:

> > > > > > hopefully, CDC is not going to follow the same pattern as the
> > > > > > history.

> > > > > > On Aug 28, 7:24 pm, harvey <xushanhua1...@gmail.com> wrote:

> > > > > > > When CDC was at $6, CDC CEO Peter Yip announced CDC was undervalued.
> > > > > > > Then CDC went to $3.
> > > > > > > When CDC was at $3,  CDC CEO Peter Yip announced CDC was undervalued.
> > > > > > > Then CDC went to $0.7.
> > > > > > > When CDC was at $0.7, CDC CEO Peter Yip didn't announce CDC was
> > > > > > > undervalued. Then CDC went to $2.6.
> > > > > > > When CDC  is at $2.6, CDC CEO Peter Yip announced CDC is undervalued.
> > > > > > > Then CDC goes to ??????????????????????.

> > > > > > > We will see!!!- Hide quoted text -

> - Show quoted text -

> Stock will hit $3 much earlier than Q3 results, perhaps might go back
> to mid 3's to 4's when Q3 comes around, perhaps new business coming in
> for CDC Software means more revenue for CDC Corp...

> On Sep 10, 11:59 am, jackson <wit...@gmail.com> wrote:

> > I did make a lot of money from CDC, when it was moving up a lot..and
> > keep on moving..
> > Was moving too fast and too much so I got out..put my $$$ into MIPS..
> > So far MIPS is doing very good.. look at that yourself ..may be a good
> > stock for you ..look at its YTD chart ...

> > On Sep 10, 11:12 am, vinip <yifeid...@gmail.com> wrote:

> > > i'm only holding my shares because my mom bought them when i todl her
> > > not to and wouldnt let me sell them when they were at 7. but yes this
> > > company is complete sh1t, so disappointing, horrible management.

> > > On Sep 3, 3:08 pm, A H <kosherricebur...@gmail.com> wrote:

> > > > CDC will in time go up again to at least $3 when Q3 results rolls
> > > > around.

> > > > On Sep 3, 9:36 am, ocean <caiwen_y...@yahoo.com> wrote:

> > > > > hopefully, CDC is not going to follow the same pattern as the
> > > > > history.

> > > > > On Aug 28, 7:24 pm, harvey <xushanhua1...@gmail.com> wrote:

> > > > > > When CDC was at $6, CDC CEO Peter Yip announced CDC was undervalued.
> > > > > > Then CDC went to $3.
> > > > > > When CDC was at $3,  CDC CEO Peter Yip announced CDC was undervalued.
> > > > > > Then CDC went to $0.7.
> > > > > > When CDC was at $0.7, CDC CEO Peter Yip didn't announce CDC was
> > > > > > undervalued. Then CDC went to $2.6.
> > > > > > When CDC  is at $2.6, CDC CEO Peter Yip announced CDC is undervalued.
> > > > > > Then CDC goes to ??????????????????????.

> > > > > > We will see!!!

> I don’t know how many people listen to the webcasting of Thomas
> Weisel
> Partners Healthcare Conference; no matter you did it or not, let’s go
> over some important details of this conference. I am sure that even
> those people who have no ideas of drug industry will admit that it is
> so unbelievable after making a comparison of LGND’s real value and
> current stock price:

> 1, LGND has 10 pharmaceutical deals, with over 21 development
> programs. The programs not only have a chance to generate substantial
> milestones, over $600 million in milestones, but also future
> royalties. For royalties incomes, please refer to AVINZA which was
> sold to King and brings ten of millions dollars royalty to LGND every
> year.

> 2, the 11 million dollars stock for stock merger agreement with NRGN
> will bring LGND about 7 million dollars hard cash plus access to
> NRGN’s pipeline. Please remember this: Just the Merck full sponsored
> pain drug VR1 will bring LGND 10 million dollars milestone payment
> once Merk start Phase 3 clinical trial. VR1 is now at Phase 2.

> NRGN also has programs for Parkinson's Disease and Insomnia.

> After listening to the webcasting, I told my friends: “this deal is
> as
> beautiful as the deal which Lakers got Pau Gasol from Grizzlies.”

> 3, I already introduced LGND’s pipeline in my last article, and there
> is a more detailed programs outline from this conference. If you are
> interested in it, you can find it in my blog at Motley Fool (my
> screen
> name is AndrewGreenBull).

> There is one thing I have to emphasize: LGND sold AVINZA and four
> other drugs to King and another Japanese company for 500+million
> dollars in 2006, and there was $2.5 dividend payout in 2007 after the
> deals were finished. Now I want to ask you readers a question, if
> LGND
> sold 21 drugs or the whole company( I believe quite a few drug makers
> are interested in it), will it cost only $2.5/Share?

> The answer is quite obvious: absolutely not! Simply think about this:
> after the merger agreement with NRGN finished by the end of this
> year,
> LGND will have total 50 million dollars cash in hand, and the current
> stock price is not even 1/5 of its real value.

> 4, there were two more big surprises from the conference:

> One is that collaboration with BMS in the area of B38 MAP kinase
> inhibitors. The collaboration started about 12 years ago. It has
> generated various leads. Right now, BMS is running three Phase II
> studies in rheumatoid arthritis, psoriasis, and arthrosclerosis. The
> larger of the three, the rheumatoid arthritis trial, completed
> accrual
> in July this year, and the data are expected next month.

> I can smell that the milestone payment is nearby.

> Another one is PROMACTA again; a lead drug partnership with GSK,
> phase
> 3 data is expected to be released at ASH in New Orleans in December.
> LGND has a potential for earning over $10 million in milestone
> payments from existing collaborations.

> P.S. don’t forget Wyeth’s and Pfizer’s 3 NDA submissions.

> When tons good news coming on the way, and the current stock price is
> below 50 days average and 200 days average, my intuition tell me that
> LGND is oversold.

> Current Price $2.37　　　　My 3 Month Target：$5　　　My One Year Target：$10

> References: Please go to my blog at Motley Fool and search my screen
> name AndrewGreenBull, and you will find them there.

> * Statement: The author of this article is not a licensed analyst and
> the purpose of this article is for information sharing and discussion
> only, not recommendation for any stock buying, selling and shorting
> activities. Please do your own research before making any trading
> decision.

> I did make a lot of money from CDC, when it was moving up a lot..and
> keep on moving..
> Was moving too fast and too much so I got out..put my $$$ into MIPS..
> So far MIPS is doing very good.. look at that yourself ..may be a good
> stock for you ..look at its YTD chart ...

> On Sep 10, 11:12 am, vinip <yifeid...@gmail.com> wrote:

> > i'm only holding my shares because my mom bought them when i todl her
> > not to and wouldnt let me sell them when they were at 7. but yes this
> > company is complete sh1t, so disappointing, horrible management.

> > On Sep 3, 3:08 pm, A H <kosherricebur...@gmail.com> wrote:

> > > CDC will in time go up again to at least $3 when Q3 results rolls
> > > around.

> > > On Sep 3, 9:36 am, ocean <caiwen_y...@yahoo.com> wrote:

> > > > hopefully, CDC is not going to follow the same pattern as the
> > > > history.

> > > > On Aug 28, 7:24 pm, harvey <xushanhua1...@gmail.com> wrote:

> > > > > When CDC was at $6, CDC CEO Peter Yip announced CDC was undervalued.
> > > > > Then CDC went to $3.
> > > > > When CDC was at $3,  CDC CEO Peter Yip announced CDC was undervalued.
> > > > > Then CDC went to $0.7.
> > > > > When CDC was at $0.7, CDC CEO Peter Yip didn't announce CDC was
> > > > > undervalued. Then CDC went to $2.6.
> > > > > When CDC  is at $2.6, CDC CEO Peter Yip announced CDC is undervalued.
> > > > > Then CDC goes to ??????????????????????.

> > > > > We will see!!!

> i'm only holding my shares because my mom bought them when i todl her
> not to and wouldnt let me sell them when they were at 7. but yes this
> company is complete sh1t, so disappointing, horrible management.

> On Sep 3, 3:08 pm, A H <kosherricebur...@gmail.com> wrote:

> > CDC will in time go up again to at least $3 when Q3 results rolls
> > around.

> > On Sep 3, 9:36 am, ocean <caiwen_y...@yahoo.com> wrote:

> > > hopefully, CDC is not going to follow the same pattern as the
> > > history.

> > > On Aug 28, 7:24 pm, harvey <xushanhua1...@gmail.com> wrote:

> > > > When CDC was at $6, CDC CEO Peter Yip announced CDC was undervalued.
> > > > Then CDC went to $3.
> > > > When CDC was at $3,  CDC CEO Peter Yip announced CDC was undervalued.
> > > > Then CDC went to $0.7.
> > > > When CDC was at $0.7, CDC CEO Peter Yip didn't announce CDC was
> > > > undervalued. Then CDC went to $2.6.
> > > > When CDC  is at $2.6, CDC CEO Peter Yip announced CDC is undervalued.
> > > > Then CDC goes to ??????????????????????.

> > > > We will see!!!

> CDC will in time go up again to at least $3 when Q3 results rolls
> around.

> On Sep 3, 9:36 am, ocean <caiwen_y...@yahoo.com> wrote:

> > hopefully, CDC is not going to follow the same pattern as the
> > history.

> > On Aug 28, 7:24 pm, harvey <xushanhua1...@gmail.com> wrote:

> > > When CDC was at $6, CDC CEO Peter Yip announced CDC was undervalued.
> > > Then CDC went to $3.
> > > When CDC was at $3,  CDC CEO Peter Yip announced CDC was undervalued.
> > > Then CDC went to $0.7.
> > > When CDC was at $0.7, CDC CEO Peter Yip didn't announce CDC was
> > > undervalued. Then CDC went to $2.6.
> > > When CDC  is at $2.6, CDC CEO Peter Yip announced CDC is undervalued.
> > > Then CDC goes to ??????????????????????.

> > > We will see!!!

> hopefully, CDC is not going to follow the same pattern as the
> history.

> On Aug 28, 7:24 pm, harvey <xushanhua1...@gmail.com> wrote:

> > When CDC was at $6, CDC CEO Peter Yip announced CDC was undervalued.
> > Then CDC went to $3.
> > When CDC was at $3,  CDC CEO Peter Yip announced CDC was undervalued.
> > Then CDC went to $0.7.
> > When CDC was at $0.7, CDC CEO Peter Yip didn't announce CDC was
> > undervalued. Then CDC went to $2.6.
> > When CDC  is at $2.6, CDC CEO Peter Yip announced CDC is undervalued.
> > Then CDC goes to ??????????????????????.

> > We will see!!!